Ivosidenib price

Ivosidenib is a drug used to treat certain types of leukemia. It belongs to a class of drugs called IDH1 inhibitors, which are used to treat specific subtypes of acute myeloid leukemia (AML) that express mutations in IDH1.

Avosidenib is already on the market in China, but it has not yet been included in medical insurance. The price of Avosidenib on the domestic market is very high, reaching tens of thousands of yuan. Please consult the local hospital pharmacy for specific prices. The price of the American original drug of Ivonib abroad is as high as hundreds of thousands. Currently, there are generic drugs of Ivonib on the market, mainly Laos generic drugs, which cost about 10,000 yuan, which is much cheaper in comparison, and the ingredients of the original drug and the generic drug are basically the same.

IDH1 is an enzyme involved in metabolic processes in cells. In some AML patients, there are mutations in the IDH1 gene, leading to abnormal activation of the enzyme, which in turn promotes the growth and proliferation of leukemia cells. The mechanism of action of ivonib is to inhibit this abnormal activation, thereby interfering with the normal function of leukemia cells.

Patients with IDH1mutated AML may experience apoptosis (cell death) and arrest of leukemia cells after treatment with ivosidenib. This helps slow down the progression of the disease and improves patients’ survival rate and quality of life.

During the treatment process, doctors usually adjust the dosage and course of treatment based on the patient's specific condition and drug response. At the same time, patients may need to undergo regular monitoring to ensure the drug's efficacy and to promptly address any potential side effects.

However, like all drugs, ivosidenib may cause some adverse reactions, such as nausea, fatigue, shortness of breath, etc. Therefore, doctors and patients need to work closely together to evaluate the effectiveness and possible risks of treatment when using this drug.